StockNews.com assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of NASDAQ:XXII opened at $0.33 on Friday. The business has a 50-day moving average price of $0.61 and a 200 day moving average price of $7.21. The company has a market capitalization of $3.05 million, a price-to-earnings ratio of 0.00 and a beta of 1.41. 22nd Century Group has a 12-month low of $0.26 and a 12-month high of $23.76.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 275.12%. The business had revenue of $7.95 million for the quarter.
Institutional Investors Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- The 3 Best Blue-Chip Stocks to Buy Now
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.